Use of Genomic Testing in Localized Prostate Cancer Can Identify Subsets of African American Patients With Aggressive Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Genomic testing in localized prostate cancer can identify subsets of African-Americans with aggressive disease
J. Natl. Cancer Inst 2022 Sep 02;[EPub Ahead of Print], S Awasthi, GD Grass, J Torres-Roca, PAS Johnstone, J Pow-Sang, J Dhillon, J Park, RJ Rounbehler, E Davicioni, A Hakansson, Y Liu, AK Fink, A DeRenzis, JH Creed, M Poch, R Li, B Manley, D Fernandez, A Naghavi, K Gage, G Lu-Yao, E Katsoulakis, RJ Burri, A Leone, CE Ercole, JD Palmer, N Vapiwala, C Deville, TR Rebbeck, AP Dicker, W Kelly, K YamoahFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.